Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
STANDARD BIOTOOLS INC. has filed 1,584 SEC EDGAR filings since 18 Jan 2002

SEC filing history

Showing 876-900 of 1,000 matching filings.

Per page
25
Current page
36
SC TO-C File 005-86635

SC TO-C

Filing date
29 Jun 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-34180

DEFINITIVE PROXY STATEMENT

Filing date
29 Jun 2017
Reporting date
01 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SD File 001-34180

SD

Filing date
31 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 May 2017
Reporting date
24 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34180

8-K

Filing date
24 May 2017
Reporting date
23 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34180

FORM 8-K

Filing date
04 May 2017
Reporting date
04 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-216542

EFFECT filing

Filing date
02 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-216542

S-3/A

Filing date
28 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-34180

10-K/A

Filing date
28 Apr 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34180

8-K ITEM 5.02(D) APPOINTMENT OF PAYA AND BARTHELEMY

Filing date
27 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
27 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
27 Mar 2017
Reporting date
23 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .